Publications scientifiques Erasme

Publications scientifiques Erasme

  • Gallbladder and Sphincter of Oddi Disorders.

  • Auteurs Elmunzer BJ, Winslow E, De Giorgio R, Laghi A, Arvanitakis M, Elta G, Corazziari E
  • Revue Gastroenterology
  • Date de publication 2026-02
Gallbladder and Sphincter of Oddi Disorders.
  • In vivo modeling of human γδ T cell ontogeny reveals terminal deoxynucleotidyl transferase as a key regulator of type 3 Vδ2 T cell development.

  • Auteurs La C, Detavernier A, Papadopoulou M, Sanchez Sanchez G, Martens V, Thomas S, Nguyen M, Acolty V, Melchior M, Venturoli D, de Toeuf B, Azouz A, Rezwani M, Tafesse Y, Verdebout I, Rongvaux A, Boehme L, Taghon T, Venken K, Elewaut D, Goriely S, Vermijlen D
  • Revue Cell Rep
  • Date de publication 2026-02
In vivo modeling of human γδ T cell ontogeny reveals terminal deoxynucleotidyl transferase as a key regulator of type 3 Vδ2 T cell development.
  • A multicentre randomized double-blind placebo-controlled study of lacosamide, pregabalin, and tapentadol on spinal pain biomarkers.

  • Auteurs Leone CM, di Pietro G, di Stefano G, Quesada C, Salameh C, Perchet C, Garcia-Larrea L, Mouraux A, Lebrun L, Gousset S, Möller-Grell N, Kostenko AV, Finnerup NB, Caspani O, Jiang B, Li T, Rong C, Genser B, Treede RD, Truini A
  • Revue Clin Neurophysiol
  • Date de publication 2026-02
A multicentre randomized double-blind placebo-controlled study of lacosamide, pregabalin, and tapentadol on spinal pain biomarkers.
  • Pathologists' experience and routine practice in high-volume lung transplant centers: An international survey.

  • Auteurs Calabrese F, Hwang DM, Lunardi F, Iannaco R, Adam J, Akyürek LM, Adam B, Jan B, Berry G, D'Sa L, Fabre A, Fattori A, Fishbein GA, Fredenburg KM, Romero TH, Husain AN, Jones K, Kern I, Lin CY, Louis R, Mancheño N, Montero-Fernandez A, Oberndorfer F, Pal P, Pavlisko EN, Qureshi MR, Remmelink M, Roden AC, Sica G, Vanstapel A, der Thüsen JV, Wein A, Weynand B, Yap FHX, Westall GP, Levine DJ
  • Revue JHLT Open
  • Date de publication 2026-02
Pathologists' experience and routine practice in high-volume lung transplant centers: An international survey.
  • ASO Visual Abstract: Adenosquamous Carcinoma of the Pancreas: Outcomes of a Multicenter European Study (ADESQUPAN Project).

  • Auteurs Ramia JM, Villodre C, Giakoustidis D, Chatzikomnitsa P, Addeo P, Bachellier P, Nappo G, Zerbi A, Navez J, Blanco-Fernández G, Kirkegård J, Busquets J, Björnsson B, Sánchez-Cabús S, Pando E, Staubli SM, Pandanaboyana S, Aparicio-López D, Spiers HVM, Melgar P, Rhaiem R, Amaral MJ, Vallejo-Bernad C, Andersson B, Burdío F, Tzimas G, Mora-Oliver I, Rousek M, Domingo-Del-Pozo C, Mahamid A, Lytras D, Lolis ED, López-Andújar R, Sorribas M, López PA, Elghonemy H, Chikkala B, Lim W, Balakrishnan A, Román MV, Ballester C, Hörndler-Algárate C, Serradilla-Martín M
  • Revue Ann Surg Oncol
  • Date de publication 2026-02
ASO Visual Abstract: Adenosquamous Carcinoma of the Pancreas: Outcomes of a Multicenter European Study (ADESQUPAN Project).
  • Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer.

  • Auteurs Gillessen S, Gallardo E, Choudhury A, Saad F, Soares A, Loriot Y, McDermott R, Rodriguez-Vida A, Isaacsson Velho P, Nolè F, Cruz F, Roumeguere T, Daugaard G, Yamamura R, Bompas E, Maroto P, Veiga FG, Skoneczna I, Martins da Trindade K, Mavignier Carcano F, Lecouvet F, Coens C, Poncet C, Fournier B, Tombal B
  • Revue Ann Oncol
  • Date de publication 2026-02
Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer.
Huderf hospital

Hôpital pédiatrique Reine Fabiola

Consultez toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola

Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet

Decorative image of doctor and patient

Toutes les publications scientifiques du H.U.B.

Consultez toutes les publications scientifiques du H.U.B.